By Andrew Karpan (June 10, 2024, 10:30 PM EDT) — A New Jersey federal judge said Monday that a handful of patents covering Teva-brand asthma inhalers were “improperly listed in the Orange Book,” a legal holding that U.S. Federal Trade Commission Chair Lina Khan quickly took some credit for….